-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Clearside Biomedical, Lowers Price Target to $5

Benzinga·05/23/2025 15:45:26
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Clearside Biomedical (NASDAQ:CLSD) with a Buy and lowers the price target from $6 to $5.